0
Skip to Content
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Nordic Migraine Symposium 2026
Home
Agenda
Venue & Accommodation
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW
Home
Agenda
Venue & Accommodation
Folder: Previous years
Back
NMS 2025
NMS 2024
NMS 2023
NMS 2022
NMS 2021
NMS 2020
NMS 2019
Contact
REGISTER NOW

Should we treat during the prodromal phase? Pro

Session 1: Migraine pathophysiology

Tine Poole

General practitioner and headache specialist, Oslo Headache Centre, Norway

Download presentation

Previous

The gut microbiota and its influence on migraine

Next

Should we treat during the prodromal phase? Con

You Might Also Like

Related Embedded Video Item Thumbnail Children and adolescent as migraine patients - Diagnosis and management
Related Embedded Video Item Thumbnail The nurse, the backbone of medical care
Related Embedded Video Item Thumbnail Should we treat during the prodromal phase? Con
Related Embedded Video Item Thumbnail Switching between anti-CGRP monoclonal antibodies and gepants
Related Embedded Video Item Thumbnail Pregnancy management and breastfeeding in migraine

Privacy policy

Teva Privacy Notice |Teva Pharmaceuticals

Legal Notes | Teva Pharmaceuticals

Accessibility Statement

Teva code of conduct

Norway, Finland, Denmark: AJO-DK-NP-00128